conclusions.tex 5.5 KB

1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556575859606162636465666768697071727374757677787980818283848586878889909192
  1. % %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
  2. % Author: Phillip Rothenbeck
  3. % Title: Your Thesis
  4. % File: conclusions/conclusions.tex
  5. % Part: conclusions
  6. % Description:
  7. % summary of the content in this chapter
  8. % Version: 01.09.2024
  9. % %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
  10. \chapter{Conclusions 5}
  11. \label{chap:conclusions}
  12. The states with the highest transmission rate
  13. values are Thuringia, Saxony Anhalt and Mecklenburg West-Pomerania. It is also,
  14. visible that all six of the eastern states have a higher transmission rate than
  15. Germany. These results may be explainable with the ratio of vaccinated individuals\footnote{\url{https://impfdashboard.de/}}.
  16. The eastern state have a comparably low complete vaccination ratio, accept for
  17. Berlin. While Berlin has a moderate vaccination ratio, it is also a hub of
  18. mobility, which means that contact between individuals happens much more often.
  19. This is also a reason for Hamburg being a state with an above national standard
  20. rate of transmission. Bremen has the highest ratio of vaccinated individuals,
  21. this might be a reason for the it having the lowest transmission of all states.\\
  22. % -------------------------------------------------------------------
  23. \section{Further Work}
  24. \label{sec:furtherWork}
  25. Our findings demonstrate that with our methods enable the quantification of the
  26. course of the COVID-19 pandemic in Germany using the data provided by the
  27. Robert Koch Institute. Additionally, we present the limitations of our work.
  28. The SIR model is subject to numerous limitations. For instance, it does not
  29. account for individuals, who may be immune due to the vaccination status or
  30. those who are not infectious due to quarantine. In this section, we explore
  31. epidemiological models that illustrate these dynamics observed in real-world
  32. pandemics and recommend further investigation for Germany. First, we examine
  33. extensions of the SIR models, then we focus on agent-based models (ABMs).
  34. % -------------------------------------------------------------------
  35. \subsection{Further Compartmental Models}
  36. As our results demonstrate, the SIR model is capable of approximating the
  37. dynamics of real-world pandemics. However, the model is not without
  38. limitations. As previously stated, the SIR model assumes that recovered
  39. individuals remain immune and does not account for the reduction of exposure of
  40. susceptible individuals through the introduction of non-pharmaceutical
  41. mitigation policies, such as social distancing policies. These shortcomings can
  42. be addressed by incorporating additional compartments and transmission rates
  43. into the model. For example, the SEIRD model incorporates an \emph{Exposed}
  44. group and subdivides the \emph{Removed} group into \emph{Dead} and
  45. \emph{Recovered} compartments. Furthermore, this adds four additional rates to
  46. the model: the contact rate, representing the average number of contacts
  47. between infectious and susceptible people with a high probability of infection;
  48. the manifestation index, indicating the proportion of individuals exposed to
  49. the disease who will become infectious; the incubation rate, measuring the time
  50. required for exposed individuals to become infectious; and the infection
  51. fatality rate, quantifying the fraction of individuals who succumb to the
  52. disease. As Doerre and Doblhammer~\cite{Doerre2022} show for Germany using a
  53. numerical approximation method, for an SIERD model that they specialize to be
  54. age- and gender-specific, that it shows the impact of non-pharmaceutical
  55. mitigation policies. In their work, Cooke and van den Driessche~\cite{Cooke1996}
  56. propose the SEIRS model with two delays. This is model is capable of
  57. approximating diseases, that have an immune period, after which the recovered
  58. individual becomes susceptible again. These are just a few examples of
  59. the numerous modifications of the basic SIR model that can be used to
  60. approximate and consequently quantify an pandemic.
  61. % -------------------------------------------------------------------
  62. \subsection{Agent based models}
  63. While compartmental models, such as the SIR model, look at the population as a
  64. divided group, with each group representing a specific characterization that
  65. all inhabitants of that group share, an \emph{Agent-Based Model} (ABM) sets its
  66. focus on the individual. Each individual, or agent, has specific attributes
  67. that determine its behavior and interactions with other agents during the
  68. simulation. As Gilbert~\cite{Gilbert2010} states, ABMs simulate the behavior of
  69. large groups, with each individual following simple rules. Kerr
  70. \etal~\cite{Kerr2021} put forth a simulation tool, \emph{Covasim}, which they
  71. base on an ABM. The ABM employs local data, including demographic data, disease
  72. incidence data from the region, and contact data for household, schools and
  73. workplaces, to define its simulation for a specific region. In their work,
  74. Maziarz and Zach~\cite{Maziarz2020} address the criticism levied against ABMs
  75. for simplifying the dynamics and lacking the empirical support for the
  76. assumptions it they make. The authors utilize an ABM and the data specific to
  77. Australia to demonstrate the efficacy of ABMs in portraying the dynamics of the
  78. COVID-19 pandemic. They further state that ABMs can serve as serve as a tool
  79. for assessing the impact of non-pharmaceutical mitigation policies. This
  80. illustrates that ABMs play a distinct role in analyzing the COVID-19 pandemic.
  81. As the data situation has evolved, it is imperative to investigate the
  82. potential of utilizing ABMs as a tool to assess the pandemic's course.
  83. % -------------------------------------------------------------------